Shattuck Labs (STTK) Assets Average (2020 - 2026)
Shattuck Labs (STTK) reported Assets Average of $96.6 million for Q1 2026, up 14.82% year-over-year from $84.1 million in Q1 2025, and up 0.93% on a QoQ basis from $95.7 million in Q4 2025.
Shattuck Labs (STTK) has 7 years of Assets Average data on file, last reported at $96.6 million in Q1 2026.
- Quarterly Assets Average rose 14.82% year-over-year to $96.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.6 million (up 14.82% YoY) and the FY2025 annual result came in at $91.0 million, down 27.35% from the prior year.
- Assets Average rose to $96.6 million in Q1 2026 per STTK's latest filing, from $95.7 million in the prior quarter.
- Across five years, Assets Average topped out at $284.5 million in Q1 2022 and bottomed at $70.8 million in Q2 2025.
- The 5-year median for Assets Average is $142.9 million (2023), against an average of $152.0 million.
- The widest annual swing landed in 2025, when Assets Average plunged 48.52%; it then increased 14.82% in 2026.
- Tracing STTK's Assets Average over 5 years: stood at $214.1 million in 2022, then sank by 32.28% to $145.0 million in 2023, then plunged by 30.08% to $101.4 million in 2024, then fell by 5.63% to $95.7 million in 2025, then gained by 0.93% to $96.6 million in 2026.
- Per Business Quant, the three latest STTK Assets Average figures stand at $96.6 million (Q1 2026), $95.7 million (Q4 2025), and $82.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Shattuck Labs | 667.80 Mn | 667.80 Mn | - | 96.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.57 Mn |
| Dec 31, 2025 | 95.68 Mn |
| Sep 30, 2025 | 82.35 Mn |
| Jun 30, 2025 | 70.77 Mn |
| Mar 31, 2025 | 84.11 Mn |
| Dec 31, 2024 | 101.38 Mn |
| Sep 30, 2024 | 120.17 Mn |
| Jun 30, 2024 | 137.47 Mn |
| Mar 31, 2024 | 152.95 Mn |
| Dec 31, 2023 | 145.01 Mn |
| Sep 30, 2023 | 142.86 Mn |
| Jun 30, 2023 | 166.47 Mn |
| Mar 31, 2023 | 191.50 Mn |
| Dec 31, 2022 | 214.13 Mn |
| Sep 30, 2022 | 237.14 Mn |
| Jun 30, 2022 | 260.92 Mn |
| Mar 31, 2022 | 284.54 Mn |
| Dec 31, 2021 | 304.58 Mn |
| Sep 30, 2021 | 317.17 Mn |
| Jun 30, 2021 | 330.32 Mn |
| Mar 31, 2021 | 342.92 Mn |
| Dec 31, 2020 | 246.92 Mn |